Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Study Identifier
M04-684
CT.gov Identifier
NCT00234897
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Rheumatoid Arthritis
    • Study Drug
  • adalimumab
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    - Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history. - Subject, based on assessment of investigator, meets the definition of active RA
    Exclusion Criteria:
    - Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study - Female subject who is pregnant or breast-feeding or considering becoming pregnant

    Protocol Summary

    The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid

    arthritis focusing on subject-reported outcomes and early response to treatment

    Study Locations

    Location
    Status
    Location
    Global Medical Information - Abbott
    North Chicago, Illinois, United States, 60064
    Status
    Not applicable